DR
DRDR.LSE iShares Healthcare Innovation UCITS ETF USD (Acc) GBP
- GBX
No recent price
- Total assets
- 995M
- Expense ratio
- 0.40%
- Dividend yield
- -
- 1-year return
- +31.65%
- Holdings
- 195
- Since
- 2016
Fund data as reported by the issuer, updated Nov 2, 2026. Total assets are in the fund's base currency.
What does DRDR.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (68.4%)
- Largest sector: Healthcare (98.0%)
- Largest region: North America (68.7%)
- Top 3 holdings: 10.0% of the fund
Asset allocation
- US stocks 68.4%
- Non-US stocks 28.8%
- Cash 0.4%
Top holdings
- Moderna Inc 5.19%
- Genmab A/S 2.67%
- Natera Inc 2.14%
- Charles River Laboratories 1.73%
- Revvity Inc. 1.72%
iShares Healthcare Innovation UCITS ETF USD (Acc) GBP performance
Sharpe ratio 0.00- This year
- +26.39%
- 1 year
- +31.65%
- 3 years
- +23.78%
- 5 years
- +2.52%
Volatility 16.1% over 1 year and 15.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DRDR.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
iShares Healthcare Innovation UCITS ETF USD (Acc) GBP top holdings
21.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 5.19% |
| Genmab A/S GMAB.CO | Healthcare | Denmark | 2.67% |
| Natera Inc NTRA.US | Healthcare | United States | 2.14% |
| Charles River Laboratories CRL.US | Healthcare | United States | 1.73% |
| Revvity Inc. RVTY.US | Healthcare | United States | 1.72% |
| IQVIA Holdings Inc IQV.US | Healthcare | United States | 1.71% |
| Illumina Inc ILMN.US | Healthcare | United States | 1.67% |
| Guardant Health Inc GH.US | Healthcare | United States | 1.64% |
| Amgen Inc AMGN.US | Healthcare | United States | 1.64% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 1.61% |
The 10 largest of 195 holdings.
DRDR.LSE sector exposure
- Healthcare98.0%
- Technology1.0%
- Industrials0.5%
- Financial Services0.2%
- Real Estate0.2%
- Basic Materials0.1%
Share of the stocks in the fund.
DRDR.LSE regional exposure
- North America68.7%
- Europe Developed14.3%
- Japan4.4%
- Asia Developed3.6%
- United Kingdom2.8%
- Asia Emerging1.1%
- Australasia0.8%
- Africa/Middle East0.0%
Share of the stocks in the fund.
Company size
Average market cap 21.9B- Mega cap5.2%
- Big cap26.1%
- Medium cap34.2%
- Small cap25.4%
- Micro cap8.9%
iShares Healthcare Innovation UCITS ETF USD (Acc) GBP fund profile
- Fund name
- iShares Healthcare Innovation UCITS ETF USD (Acc) GBP
- Ticker
- DRDR.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Sep 8, 2016
- Trading currency
- GBX
- Expense ratio
- 0.40%